가축용 백신 시장 보고서 : 동향, 예측 및 경쟁 분석(-2030년)

Livestock Vaccine Trends and Forecast

The future of the global livestock vaccine market looks promising with opportunities in the live attenuated, inactivated, toxoid, and recombinant markets. The global livestock vaccine market is expected to reach an estimated $6.9 billion by 2030 with a CAGR of 4.1% from 2024 to 2030. The major drivers for this market are high demand for livestock products such as meat and dairy products and growing prevelence of certain diseases in livestock animals.

A more than 150-page report is developed to help in your business decisions.

Livestock Vaccine by Segment

The study includes a forecast for the global livestock vaccine by product type, technology, and region.

Livestock Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Bovine Vaccine
• Poultry Vaccine
• Porcine Vaccine
• Others

Livestock Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Live Attenuated Vaccine
• Inactivated Vaccine
• Toxoid Vaccine
• Recombinant Vaccine
• Others

Livestock Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Livestock Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies livestock vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the livestock vaccine companies profiled in this report include-

• Merck
• Pfizer
• AgriLabs
• Zoetis
• Novartis
• Boehringer Ingelheim
• Bayer
• Eli Lilly
• Virbac
• Neogen

Livestock Vaccine Market Insights

Lucintel forecasts that poultry will remain the largest segment due to growing demand for preventive vaccines among farmers to prevent future poultry production loss.

North America is expected to witness highest growth over the forecast period due to rising adoption of veterinary vaccines for quality food products and for better animal health and presence of key players in the region.

Features of the Global Livestock Vaccine Market

Market Size Estimates: Livestock vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Livestock vaccine market size by product type, technology, and region in terms of value ($B).

Regional Analysis: Livestock vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, and regions for the livestock vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the livestock vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the livestock vaccine market size?

Answer: The global livestock vaccine market is expected to reach an estimated $6.9 billion by 2030.

Q.2 What is the growth forecast for livestock vaccine market?

Answer: The global livestock vaccine market is expected to grow with a CAGR of 4.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the livestock vaccine market?

Answer: The major drivers for this market are high demand for livestock products such as meat and dairy products and growing prevelence of certain diseases in livestock animals.

Q4. What are the major segments for livestock vaccine market?

Answer: The future of the livestock vaccine market looks promising with opportunities in the live attenuated, inactivated, toxoid, and recombinant markets.

Q5. Who are the key livestock vaccine market companies?

Answer: Some of the key livestock vaccine companies are as follows:

• Merck
• Pfizer
• AgriLabs
• Zoetis
• Novartis
• Boehringer Ingelheim
• Bayer
• Eli Lilly
• Virbac
• Neogen

Q6. Which livestock vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that poultry will remain the largest segment due to growing demand for preventive vaccines among farmers to prevent future poultry production loss.

Q7. In livestock vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising adoption of veterinary vaccines for quality food products and for better animal health and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the livestock vaccine market by product type (bovine vaccine, poultry vaccine, porcine vaccine, and others), technology (live attenuated vaccine, inactivated vaccine, toxoid vaccine, recombinant vaccine, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Livestock Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Livestock Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Livestock Vaccine Market by Product Type
  • 3.3.1: Bovine Vaccine
  • 3.3.2: Poultry Vaccine
  • 3.3.3: Porcine Vaccine
  • 3.3.4: Others
• 3.4: Global Livestock Vaccine Market by Technology
  • 3.4.1: Live Attenuated Vaccine
  • 3.4.2: Inactivated Vaccine
  • 3.4.3: Toxoid Vaccine
  • 3.4.4: Recombinant Vaccine
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Livestock Vaccine Market by Region
• 4.2: North American Livestock Vaccine Market
  • 4.2.2: North American Livestock Vaccine Market by Technology: Live Attenuated Vaccine, Inactivated Vaccine, Toxoid Vaccine, Recombinant Vaccine, and Others
• 4.3: European Livestock Vaccine Market
  • 4.3.1: European Livestock Vaccine Market by Product Type: Bovine Vaccine, Poultry Vaccine, Porcine Vaccine, and Others
  • 4.3.2: European Livestock Vaccine Market by Technology: Live Attenuated Vaccine, Inactivated Vaccine, Toxoid Vaccine, Recombinant Vaccine, and Others
• 4.4: APAC Livestock Vaccine Market
  • 4.4.1: APAC Livestock Vaccine Market by Product Type: Bovine Vaccine, Poultry Vaccine, Porcine Vaccine, and Others
  • 4.4.2: APAC Livestock Vaccine Market by Technology: Live Attenuated Vaccine, Inactivated Vaccine, Toxoid Vaccine, Recombinant Vaccine, and Others
• 4.5: ROW Livestock Vaccine Market
  • 4.5.1: ROW Livestock Vaccine Market by Product Type: Bovine Vaccine, Poultry Vaccine, Porcine Vaccine, and Others
  • 4.5.2: ROW Livestock Vaccine Market by Technology: Live Attenuated Vaccine, Inactivated Vaccine, Toxoid Vaccine, Recombinant Vaccine, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Livestock Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Livestock Vaccine Market by Technology
  • 6.1.3: Growth Opportunities for the Global Livestock Vaccine Market by Region
• 6.2: Emerging Trends in the Global Livestock Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Livestock Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Livestock Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Merck
• 7.2: Pfizer
• 7.3: AgriLabs
• 7.4: Zoetis
• 7.5: Novartis
• 7.6: Boehringer Ingelheim
• 7.7: Bayer
• 7.8: Eli Lilly
• 7.9: Virbac
• 7.10: Neogen